(Q39244731)

English

HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Fanzhi Meng

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Shoumei Zhen

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Bin Song

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

11 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Acta Pathologica et Microbiologica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

125

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

743-751

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Hepatocellular carcinoma--epidemiological trends and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Hepatitis B and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Long-term outcomes in hepatitis B: the REVEAL-HBV study

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

T-cell responses in hepatitis B and C virus infection: similarities and differences

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Potential of immunotherapy for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Immune control of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Hepatitis B virus genotypes: global distribution and clinical importance

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Tumor regulatory T cells potently abrogate antitumor immunity

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Tregs and rethinking cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

CD4(+)CD8(dim) T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Cytotoxic CD4 T cells in antiviral immunity

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Cytotoxic human CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1111%2FAPM.12704

21 January 2018

Identifiers

10.1111/APM.12704

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

release_2sw36poixbcxto2ybtcnvyascu

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39244731&oldid=1815850933"